Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Nocturia
- Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women
- A Post Approval Study to Investigate the Efficacy of Daridorexant in Subjects With Insomnia and Comorbid Nocturia
- Effectiveness of Bryophyllum in Nocturia-Therapy
- NOGO for an Overactive Bladder
- Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
- Treating Nocturnal Hypertension and Nocturia in African American Men
- A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults
- Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
- Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
- Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects
- Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects
- Bioavailability of [14C]-SK-1404 ADME & IV Microtracer Study
- Investigation of the Effect of the Female Urinary Microbiome on Incontinence
- Paxerol™ for Treatment of Nocturia - A Phase II Placebo-Controlled Trial
- Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
- Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon
- Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
- Melatonin for Nocturia in Parkinson's Disease
- Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older
- The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
- Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
- Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia
- The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion
- Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4
- Daytime Impact Sleep Study
- Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
- Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men
- Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women
- Dose Range Finding Study of Fedovapagon in Men With Nocturia
- Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary
- Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients
- Efficacy and Safety of Gabapentin in Treating Overactive Bladder
- Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study
- Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study
- Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia
- Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)
- Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients
- Study to Investigate the Safety and Pharmacokinetics of SER120 Nasal Spray in Elderly Patients With Nocturia
- Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients
- Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
- VA106483 Dose Response in Females
- Efficacy Study of VA106483 in Males With Nocturia.
- Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness
- Long Term Safety Assessment of SER120 in Patients With Nocturia
- Treatment of Patients With Nocturia
- Treatment of Patients With Nocturia (Non-PK Study)
- VA106483 Dose Response Study in Elderly Males
- Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity
- Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)
- VA106483 and Alpha Blocker Interaction Study in Elderly Males
- Efficacy and Safety of VA106483 in Elderly Males
- Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)
- Behavior and Exercise Versus Drug Treatment in Men With Nocturia (BEDTiMe)
- A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
- Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men
- An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults
- Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia